Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.3%

1 terminated out of 23 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed with results

Key Signals

1 with results88% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (7)
P 2 (3)
P 4 (2)

Trial Status

Completed7
Active Not Recruiting6
Unknown4
Withdrawn2
Terminated1
Enrolling By Invitation1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT06505200Active Not Recruiting

Observational Cohort Study Renal Transplantation University Hospitals Leuven

NCT07555106Phase 2Active Not Recruiting

Dapagliflozin in Living-Donor Kidney Transplant Recipients

NCT05897047Not ApplicableActive Not Recruiting

The smartNTx Trial:Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR)

NCT07269275CompletedPrimary

HLA Eplet Mismatches to Predict Long-term Kidney Transplant Outcomes

NCT06186843Not ApplicableActive Not Recruiting

Plant-based Diet for Kidney Transplant Recipients

NCT03689075Phase 4TerminatedPrimary

Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation

NCT05788276Phase 4Recruiting

Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?

NCT05285878Phase 2Enrolling By Invitation

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

NCT06802822Not ApplicableNot Yet Recruiting

Prevent Allosensitization in Patients Who Have Failed a First Renal Transplant (PART)

NCT04897438Not ApplicableCompleted

Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection

NCT06056518Not ApplicableActive Not RecruitingPrimary

Investigating the Impact of AI on Shared Decision Making in Post-kidney Transplant Care

NCT06020534Completed

Aortoiliac Stenosis in Kidney Transplantation

NCT04882254Phase 2Active Not RecruitingPrimary

Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes?

NCT05619679CompletedPrimary

A Clinical Practice Snapshot on Pediatric Kidney Transplantation

NCT04560582Withdrawn

Immunosuppression Reduction in Failed Allograft Guided by cfDNA

NCT04154267Not ApplicableUnknown

Protocol Biopsies in High-risk Renal Transplant Recipients

NCT04918199CompletedPrimary

Human Versus Computer-based Predictions of Long Allograft Survival

NCT05200949CompletedPrimary

SURGICAL EXPERIENCE ON RENAL TRANSPLANT COMPLICATIONS

NCT04216303Withdrawn

Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus

NCT02960802Not ApplicableUnknownPrimary

Kidney Transplantation and Renal and Myocardial Perfusion

Scroll to load more

Research Network

Activity Timeline